Previous studies showed that full-thickness wounds in transforming growth f
actor-beta 1-deficient mice initially heal normally. Unfortunately, transfo
rming growth factor-beta 1 deficiency leads to a multifocal inflammatory di
sease affecting most organs of the body, which ultimately interferes with l
ater stages of wound healing in these mice. As this inflammatory disease is
eliminated in transforming growth factor-beta 1-deficient mice lacking T a
nd B cells (Tgfb1(-/-) Scid(-/-) mice), we hypothesized that wound repair i
n the latter would proceed normally, even at later stages of healing. Unexp
ectedly, Tgfb1(-/-) Scid(-/-) mice demonstrate a major delay of approximate
ly 1 wk in each of the major phases of wound healing: inflammation, prolife
ration, and maturation. Immunodeficient Scid(-/-) mice that have the wild-t
ype Tgfb1 allele do not experience this delay in wound healing. One interpr
etation of these findings is that lymphocytes and transforming growth facto
r-beta 1 affect compensatory pathways in wound healing. An alternative inte
rpretation is that the delayed expression of Tgfb2 and Tgfb3 that occurs in
the absence of transforming growth factor-beta 1 results in the delayed wo
und healing, suggesting that transforming growth factor-beta 2 and/or trans
forming growth factor-beta 3 play important parts in wound healing.